Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Rheumatol. 1996 Sep;8(5):430-7.

Prognosis and treatment of systemic lupus erythematosus.

Author information

1
University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Hospital, Ontario, Canada.

Abstract

This article summarizes the evidence for the improved prognosis in patients with systemic lupus erythematosus (SLE). It discusses the reasons for improved survival, as well as the risk for mortality, which still remains high for patients with this disease. Causes of death are reviewed, and prognostic factors examined. Other outcome measures for prognosis in SLE, including specific organ damage, accumulated damage index, and health status and quality of life are considered. Recent articles on therapy for SLE are discussed.

PMID:
8941446
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Loading ...
    Support Center